Press "Enter" to skip to content

Celsion’s GEN-1 Immunotherapy Highlighted in Oppenheimer’s Expert Call on Ovarian Cancer Treatment Landscape and Emerging Opportunities – Nasdaq

admin 0

Celsion’s GEN-1 Immunotherapy Highlighted in Oppenheimer’s Expert Call on Ovarian Cancer Treatment Landscape and Emerging Opportunities  Nasdaq

Presentation Slides Available on Celsion’ s Website. LAWRENCEVILLE, N.J, Aug. 09, 2019– Celsion Corporation, an oncology drug-development company,.

“liver cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *